{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:43:12Z","timestamp":1765485792305,"version":"3.48.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019655","name":"ICW Healthcare Ventures","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI170159-01A1"],"award-info":[{"award-number":["R21AI170159-01A1"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI170159-01A1"],"award-info":[{"award-number":["R21AI170159-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jmii.2025.05.005","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T02:54:32Z","timestamp":1747968872000},"page":"688-694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of COVID-19 vaccination and past SARS-CoV-2 infection on subsequent COVID-19 infection in people with HIV"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6788-0688","authenticated-orcid":false,"given":"Xueying","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanghui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1229-0477","authenticated-orcid":false,"given":"Yangjianchen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Poland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bankole","family":"Olatosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2025.05.005_bib1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijid.2021.11.009","article-title":"Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis","volume":"114","author":"Zheng","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"10379","key":"10.1016\/j.jmii.2025.05.005_bib2","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0140-6736(22)02465-5","article-title":"Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis","volume":"401","author":"Stein","year":"2023","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jmii.2025.05.005_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jiph.2023.01.020","article-title":"Implications for COVID-19 vaccine uptake: a systematic review","volume":"16","author":"Adu","year":"2023","journal-title":"J. Infect. Public Health"},{"issue":"1","key":"10.1016\/j.jmii.2025.05.005_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2507","article-title":"Safety and efficacy of COVID\u201019 vaccines: a systematic review and meta\u2010analysis of controlled and randomized clinical trials","volume":"34","author":"Beladiya","year":"2024","journal-title":"Rev Med Virol"},{"issue":"10262","key":"10.1016\/j.jmii.2025.05.005_bib5","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0140-6736(20)32137-1","article-title":"SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates","volume":"396","author":"Poland","year":"2020","journal-title":"Lancet"},{"issue":"10328","key":"10.1016\/j.jmii.2025.05.005_bib6","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","article-title":"Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression","volume":"399","author":"Feikin","year":"2022","journal-title":"The lancet"},{"issue":"2","key":"10.1016\/j.jmii.2025.05.005_bib7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/vaccines11020224","article-title":"A systematic review and meta-analysis on the real-world effectiveness of COVID-19 vaccines against infection, symptomatic and severe COVID-19 disease caused by the omicron variant (B. 1.1. 529)","volume":"11","author":"Mohammed","year":"2023","journal-title":"Vaccines"},{"issue":"11","key":"10.1016\/j.jmii.2025.05.005_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac579","article-title":"A systematic review of COVID-19 vaccine antibody responses in people with HIV","volume":"9","author":"Chun","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jmii.2025.05.005_bib9","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijid.2022.10.005","article-title":"Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis","volume":"124","author":"Yin","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"5","key":"10.1016\/j.jmii.2025.05.005_bib10","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/hiv.13202","article-title":"Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy","volume":"23","author":"Jedicke","year":"2022","journal-title":"HIV Med"},{"issue":"2","key":"10.1016\/j.jmii.2025.05.005_bib11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/hiv.13188","article-title":"Qualitative assessment of anti\u2010SARS\u2010CoV\u20102 spike protein immunogenicity (QUASI) after COVID\u201019 vaccination in older people living with HIV","volume":"23","author":"Tuan","year":"2022","journal-title":"HIV Med"},{"issue":"3","key":"10.1016\/j.jmii.2025.05.005_bib12","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/vaccines11030514","article-title":"The clinical effectiveness and safety of vaccinations against COVID-19 in HIV-positive patients: data from observational study in Poland","volume":"11","author":"Bie\u0144kowski","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.jmii.2025.05.005_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijid.2023.11.029","article-title":"COVID-19 breakthrough infections among people living with and without HIV: a statewide cohort analysis","volume":"139","author":"Yang","year":"2024","journal-title":"Int J Infect Dis"},{"year":"2024","series-title":"Real-world Effectiveness of COVID-19 Vaccine in People with HIV Compared with a Matched HIV-Negative Cohort: A Test-Negative Design","author":"Yang","key":"10.1016\/j.jmii.2025.05.005_bib14"},{"issue":"7","key":"10.1016\/j.jmii.2025.05.005_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027688","article-title":"Using big data analytics to improve HIV medical care utilisation in South Carolina: a study protocol","volume":"9","author":"Olatosi","year":"2019","journal-title":"BMJ Open"},{"issue":"8","key":"10.1016\/j.jmii.2025.05.005_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-067095","article-title":"COVID-19 vaccine effectiveness among people living with and without HIV in South Carolina, USA: protocol of a population-based cohort study","volume":"12","author":"Yang","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.jmii.2025.05.005_bib17","series-title":"Office of the Assistant Secretary for Preparedness and Response","article-title":"Standardized surveillance case definition and national notification for 2019 novel coronavirus disease (COVID-19)","author":"State","year":"2020"},{"key":"10.1016\/j.jmii.2025.05.005_bib18","unstructured":"Prevention CfDCa. SARS-CoV-2 Variant Classifications and Definitions [cited 2023 August 14] [Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/variants\/variant-classifications.html."},{"issue":"20","key":"10.1016\/j.jmii.2025.05.005_bib19","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.2021.19499","article-title":"Association between mRNA vaccination and COVID-19 hospitalization and disease severity","volume":"326","author":"Tenforde","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jmii.2025.05.005_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jamainternmed.2021.7024","article-title":"Association between immune dysfunction and COVID-19 breakthrough infection after SARS-CoV-2 vaccination in the US","volume":"182","author":"Sun","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"15","key":"10.1016\/j.jmii.2025.05.005_bib21","doi-asserted-by":"crossref","first-page":"F17","DOI":"10.1097\/QAD.0000000000003405","article-title":"Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people living with HIV","volume":"36","author":"Chambers","year":"2022","journal-title":"Aids"},{"author":"Policy","key":"10.1016\/j.jmii.2025.05.005_bib22"},{"issue":"4","key":"10.1016\/j.jmii.2025.05.005_bib23","first-page":"188","article-title":"Charlson comorbidity index: ICD-9 update and ICD-10 translation","volume":"12","author":"Glasheen","year":"2019","journal-title":"American health & drug benefits"},{"issue":"14","key":"10.1016\/j.jmii.2025.05.005_bib24","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1001\/jama.2022.17876","article-title":"Association of primary and booster vaccination and prior infection with SARS-CoV-2 infection and severe COVID-19 outcomes","volume":"328","author":"Lin","year":"2022","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.jmii.2025.05.005_bib25","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1473-3099(23)00272-4","article-title":"Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on omicron infection and severe outcomes in children under 12 years of age in the USA: an observational cohort study","volume":"23","author":"Lin","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jmii.2025.05.005_bib26","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2352-3018(22)00033-9","article-title":"Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study","volume":"9","author":"Netto","year":"2022","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jmii.2025.05.005_bib27","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3389\/fimmu.2017.01380","article-title":"T follicular helper cells and B cell dysfunction in aging and HIV-1 infection","volume":"8","author":"Pallikkuth","year":"2017","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jmii.2025.05.005_bib28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41423-023-01087-w","article-title":"The immune response to SARS-CoV-2 in people with HIV","volume":"21","author":"H\u00f6ft","year":"2024","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"10.1016\/j.jmii.2025.05.005_bib29","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/cid\/cit937","article-title":"Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis","volume":"58","author":"Kern\u00e9is","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jmii.2025.05.005_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/oxfimm\/iqac005","article-title":"SARS-CoV-2 immunity and vaccine strategies in people with HIV","volume":"3","author":"Mullender","year":"2022","journal-title":"Oxf. open immunol."},{"key":"10.1016\/j.jmii.2025.05.005_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-068632","article-title":"Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis","volume":"376","author":"Lee","year":"2022","journal-title":"Bmj"},{"issue":"6","key":"10.1016\/j.jmii.2025.05.005_bib32","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S2352-3018(21)00072-2","article-title":"SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study","volume":"8","author":"Spinelli","year":"2021","journal-title":"The lancet HIV"},{"issue":"4","key":"10.1016\/j.jmii.2025.05.005_bib33","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.amjmed.2018.12.011","article-title":"Vaccination in the adult patient infected with HIV: a review of vaccine efficacy and immunogenicity","volume":"132","author":"El Chaer","year":"2019","journal-title":"Am J Med"},{"key":"10.1016\/j.jmii.2025.05.005_bib34","article-title":"Comparative effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines in immunocompromised individuals: a systematic review and meta-analysis using the GRADE framework","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jmii.2025.05.005_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.727850","article-title":"Humoral and cellular response following vaccination with the BNT162b2 mRNA COVID-19 vaccine in patients affected by primary immunodeficiencies","volume":"12","author":"Amodio","year":"2021","journal-title":"Front Immunol"},{"issue":"23","key":"10.1016\/j.jmii.2025.05.005_bib36","first-page":"3165","article-title":"Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Blood","volume":"137","author":"Herishanu","year":"2021","journal-title":"The Journal of the American Society of Hematology"},{"issue":"6","key":"10.1016\/j.jmii.2025.05.005_bib37","doi-asserted-by":"crossref","first-page":"677","DOI":"10.5858\/arpa.2021-0607-SA","article-title":"Comparison of symptoms and antibody response following administration of Moderna or Pfizer SARS-CoV-2 vaccines","volume":"146","author":"Kelliher","year":"2022","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.jmii.2025.05.005_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2451","article-title":"Humoral immune response to two doses of COVID\u201019 mRNA\u2010based vaccines in people living with HIV: a systematic review and meta\u2010analysis","volume":"33","author":"Farhadian","year":"2023","journal-title":"Rev Med Virol"},{"issue":"7","key":"10.1016\/j.jmii.2025.05.005_bib39","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jama.2022.0210","article-title":"Comparison of mRNA-1273 and BNT162b2 vaccines on breakthrough SARS-CoV-2 infections, hospitalizations, and death during the delta-predominant period","volume":"327","author":"Wang","year":"2022","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jmii.2025.05.005_bib40","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/ccr3.3786","article-title":"COVID\u201019: prolonged viral shedding in an HIV patient with literature review of risk factors for prolonged viral shedding and its implications for isolation strategies","volume":"9","author":"Yousaf","year":"2021","journal-title":"Clin. Case Rep."}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118225001045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118225001045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:32:23Z","timestamp":1765485143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118225001045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1684118225001045"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2025.05.005","relation":{},"ISSN":["1684-1182"],"issn-type":[{"type":"print","value":"1684-1182"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of COVID-19 vaccination and past SARS-CoV-2 infection on subsequent COVID-19 infection in people with HIV","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2025.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}